echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JOS: use of mechanical thrombectomy in acute stroke patients with moderate to severe pre-stroke disability

    JOS: use of mechanical thrombectomy in acute stroke patients with moderate to severe pre-stroke disability

    • Last Update: 2022-11-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Several randomized trials have demonstrated the effectiveness
    of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) with large vessel occlusion (LVO) and pre-morbidly modified Rankin Scale (mRS) score <2.
    However, research on mechanical thrombectomy (MT) in patients with acute ischaemic stroke (AIS) is limited
    .
    The study aimed to compare the outcomes
    of MT with optimal medical treatment (BMT) in these patients.

    Nationwide, 462 patients with AIS with pre-stroke disability (modified Rankin Scale [mRS] score ≥3) and acute macrovascular occlusion were identified in the Austrian and Swiss single-centre registers
    .
    The primary outcome was a return to pre-stroke mRS or better
    within 3 months.
    Secondary outcomes were early neurological improvement (NIHSS improved ≥ score 8 at 24 to 48 hours), 3-month mortality, and symptomatic intracerebral hemorrhage (sICH).

    The results showed that compared with the BMT group (n=175), the MT group (n=175) had a younger age, more severe stroke, and lower mRS before stroke, but a similar
    proportion of intravenous thrombolytic therapy.
    MT was associated with a higher chance of returning to baseline mRS or better at three months (aOR = 2.
    5; 95% confidence interval [CI], 1.
    39 to 4.
    47), better early neurological improvement (aOR = 2.
    62; 95% CI, 1.
    41 to 4.
    88), and a lower risk of death at three months (aOR = 0.
    29; 95% CI, 0.
    18 to 0.
    49).

    However, MT was not associated with an increased risk of sICH (4.
    0% vs.
    2.
    1% of all patients; 4.
    2% vs.
    2.
    4% in the PSM cohort
    .

    In summary, MT in patients with pre-stroke mRS≥3 may improve outcomes at 3 months and short-term neurological damage, suggesting that pre-stroke disability should not be a reason
    to refuse MT.

     

    References:

    Mechanical Thrombectomy in Acute Stroke Patients with Moderate to Severe Pre-Stroke Disability.
    DOI: https://doi.
    org/10.
    5853/jos.
    2022.
    00906

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.